CL2015001180A1 - Combinacion farmaceutica que comprende un copolimero de carboximetilcelulosa sodica con un grado de sustitucion de 0,35 a 0,80 y gosipol o un medicamento para el tratamiento de trastornos cognitivos seleccionado de neurolepticos, antidepresivos, anticonvulsivos o una combinacion de los mismos. - Google Patents
Combinacion farmaceutica que comprende un copolimero de carboximetilcelulosa sodica con un grado de sustitucion de 0,35 a 0,80 y gosipol o un medicamento para el tratamiento de trastornos cognitivos seleccionado de neurolepticos, antidepresivos, anticonvulsivos o una combinacion de los mismos.Info
- Publication number
- CL2015001180A1 CL2015001180A1 CL2015001180A CL2015001180A CL2015001180A1 CL 2015001180 A1 CL2015001180 A1 CL 2015001180A1 CL 2015001180 A CL2015001180 A CL 2015001180A CL 2015001180 A CL2015001180 A CL 2015001180A CL 2015001180 A1 CL2015001180 A1 CL 2015001180A1
- Authority
- CL
- Chile
- Prior art keywords
- combination
- gosipol
- neuroleptics
- anticonvulsants
- antidepressants
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/717—Celluloses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B11/00—Preparation of cellulose ethers
- C08B11/02—Alkyl or cycloalkyl ethers
- C08B11/04—Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals
- C08B11/10—Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals substituted with acid radicals
- C08B11/12—Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals substituted with acid radicals substituted with carboxylic radicals, e.g. carboxymethylcellulose [CMC]
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B15/00—Preparation of other cellulose derivatives or modified cellulose, e.g. complexes
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B15/00—Preparation of other cellulose derivatives or modified cellulose, e.g. complexes
- C08B15/02—Oxycellulose; Hydrocellulose; Cellulosehydrate, e.g. microcrystalline cellulose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Polymers & Plastics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2010141697/05A RU2453559C1 (ru) | 2010-10-11 | 2010-10-11 | Способ получения сополимера натрийкарбоксиметилцеллюлозы и госсипола и его применение в комплексной терапии пациентов с аутистическими расстройствами и когнитивными нарушениями |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2015001180A1 true CL2015001180A1 (es) | 2015-08-28 |
Family
ID=45938511
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2013000962A CL2013000962A1 (es) | 2010-10-11 | 2013-04-10 | Metodo para porducir un copolimero de carboximetilcelulosa sodica con un grado de sustitucion de 0,35 a 0,80 y gosipol; composicion farmaceutica; combinacion que lo comprende junto a uno o mas medicamentos neurolepticos, antidepresivos o anticonvulsivos; metodo de tratamiento; y uso en trastornos autistas y alteraciones cognitivas. |
CL2015001180A CL2015001180A1 (es) | 2010-10-11 | 2015-05-05 | Combinacion farmaceutica que comprende un copolimero de carboximetilcelulosa sodica con un grado de sustitucion de 0,35 a 0,80 y gosipol o un medicamento para el tratamiento de trastornos cognitivos seleccionado de neurolepticos, antidepresivos, anticonvulsivos o una combinacion de los mismos. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2013000962A CL2013000962A1 (es) | 2010-10-11 | 2013-04-10 | Metodo para porducir un copolimero de carboximetilcelulosa sodica con un grado de sustitucion de 0,35 a 0,80 y gosipol; composicion farmaceutica; combinacion que lo comprende junto a uno o mas medicamentos neurolepticos, antidepresivos o anticonvulsivos; metodo de tratamiento; y uso en trastornos autistas y alteraciones cognitivas. |
Country Status (26)
Country | Link |
---|---|
US (1) | US9078916B2 (es) |
EP (1) | EP2628754B8 (es) |
JP (1) | JP5690944B2 (es) |
CN (1) | CN103189393B (es) |
AU (1) | AU2011314406B2 (es) |
BR (1) | BR112013008888B1 (es) |
CA (2) | CA2896450A1 (es) |
CL (2) | CL2013000962A1 (es) |
CO (1) | CO6731081A2 (es) |
CY (1) | CY1119413T1 (es) |
DK (1) | DK2628754T3 (es) |
EA (2) | EA024810B1 (es) |
EC (1) | ECSP13012613A (es) |
ES (1) | ES2643167T3 (es) |
GE (1) | GEP201706607B (es) |
HR (1) | HRP20171330T1 (es) |
HU (1) | HUE034920T2 (es) |
LT (1) | LT2628754T (es) |
PE (1) | PE20140200A1 (es) |
PL (1) | PL2628754T3 (es) |
PT (1) | PT2628754T (es) |
RS (1) | RS56257B1 (es) |
RU (1) | RU2453559C1 (es) |
SI (1) | SI2628754T1 (es) |
UA (2) | UA108126C2 (es) |
WO (1) | WO2012050483A1 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2499002C1 (ru) * | 2012-06-14 | 2013-11-20 | Общество С Ограниченной Ответственностью "Ниармедик Плюс" | Конъюгаты госсипола и натрийкарбоксиметилцеллюлозы, способы их получения и противовирусные средства на их основе |
RU2577539C2 (ru) * | 2014-06-17 | 2016-03-20 | Общество С Ограниченной Ответственностью "Ниармедик Плюс" | Полимерные производные госсипола, способ их получения и фармацевтическая композиция на их основе |
RU2754067C2 (ru) * | 2018-05-18 | 2021-08-25 | Общество с ограниченной ответственностью "НИАРМЕДИК ФАРМА" | Противомикробная композиция на основе полифенолов и полисахаридов, способ ее получения и применение |
RU2746504C1 (ru) * | 2020-02-27 | 2021-04-14 | Ниармедик Интернэшнл Лимитед | Противомикробные средства на основе бета-глюканов, способы их получения и применения |
JP7207364B2 (ja) | 2020-05-19 | 2023-01-18 | Jfeスチール株式会社 | ロッドミルのロッド交換装置及び方法 |
CN114622407B (zh) * | 2022-04-01 | 2023-09-19 | 浙江隆腾医用新材料有限公司 | 一种羧甲基纤维素钠纤维的洗脱方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2002755C1 (ru) * | 1991-02-04 | 1993-11-15 | Научно-исследовательский институт эпидемиологии и микробиологии им.Н.Ф.Гамалеи РАМН | Производное целлюлозы и госсипола, обладающее интерферониндуцирующим и противовирусным действием |
RU2222548C2 (ru) * | 2000-07-21 | 2004-01-27 | Зао "Ниармедик Плюс" | Применение производного целлюлозы и госсипола в качестве радиопротекторного, противоинфекционного и потенциирующего средства, усовершенствованный способ его получения и фармацевтическая композиция на его основе |
JP4445853B2 (ja) * | 2002-06-10 | 2010-04-07 | ワイス エルエルシー | 新規o−デスメチルベンラファクシンギ酸塩 |
DE10226494A1 (de) * | 2002-06-14 | 2004-01-08 | Lts Lohmann Therapie-Systeme Ag | Filmförmige mucoadhäsive Darreichungsformen zur Verabreichung von Cannabis-Wirkstoffen |
RU2238122C1 (ru) * | 2003-01-20 | 2004-10-20 | Ооо "Ниармедик Плюс" | Противоинфекционный фармацевтический препарат |
RU2270708C1 (ru) * | 2004-05-26 | 2006-02-27 | Ооо "Ниармедик Плюс" | Натриевая соль сополимера карбоксиметилцеллюлозы и госсипола, фармацевтическая композиция и способ профилактики или лечения вирусных заболеваний |
US20060144723A1 (en) * | 2004-11-02 | 2006-07-06 | Mary Fuller | Device for securing valuables |
US20070003621A1 (en) * | 2005-06-23 | 2007-01-04 | Spherics, Inc. | Dosage forms for movement disorder treatment |
US20090285865A1 (en) * | 2008-05-14 | 2009-11-19 | Shalaby Shalaby W | Palatable, solid oral formulations for male chemical sterilization |
-
2010
- 2010-10-11 RU RU2010141697/05A patent/RU2453559C1/ru active
-
2011
- 2011-06-10 UA UAA201305876A patent/UA108126C2/ru unknown
- 2011-10-06 AU AU2011314406A patent/AU2011314406B2/en not_active Ceased
- 2011-10-06 EA EA201390530A patent/EA024810B1/ru active IP Right Revival
- 2011-10-06 CA CA2896450A patent/CA2896450A1/en not_active Abandoned
- 2011-10-06 ES ES11832823.6T patent/ES2643167T3/es active Active
- 2011-10-06 GE GEAP201113083A patent/GEP201706607B/en unknown
- 2011-10-06 RS RS20170877A patent/RS56257B1/sr unknown
- 2011-10-06 SI SI201131286T patent/SI2628754T1/en unknown
- 2011-10-06 PL PL11832823T patent/PL2628754T3/pl unknown
- 2011-10-06 WO PCT/RU2011/000785 patent/WO2012050483A1/ru active Application Filing
- 2011-10-06 JP JP2013533814A patent/JP5690944B2/ja not_active Expired - Fee Related
- 2011-10-06 US US13/877,416 patent/US9078916B2/en not_active Expired - Fee Related
- 2011-10-06 LT LTEP11832823.6T patent/LT2628754T/lt unknown
- 2011-10-06 BR BR112013008888-5A patent/BR112013008888B1/pt not_active IP Right Cessation
- 2011-10-06 HU HUE11832823A patent/HUE034920T2/en unknown
- 2011-10-06 UA UAA201411350A patent/UA108975C2/ru unknown
- 2011-10-06 EA EA201690544A patent/EA031316B1/ru active IP Right Revival
- 2011-10-06 PT PT118328236T patent/PT2628754T/pt unknown
- 2011-10-06 DK DK11832823.6T patent/DK2628754T3/da active
- 2011-10-06 PE PE2013000829A patent/PE20140200A1/es active IP Right Grant
- 2011-10-06 CA CA2811583A patent/CA2811583C/en not_active Expired - Fee Related
- 2011-10-06 EP EP11832823.6A patent/EP2628754B8/en active Active
- 2011-10-06 CN CN201180048898.4A patent/CN103189393B/zh not_active Expired - Fee Related
-
2013
- 2013-04-10 CL CL2013000962A patent/CL2013000962A1/es unknown
- 2013-05-09 EC ECSP13012613 patent/ECSP13012613A/es unknown
- 2013-05-10 CO CO13117014A patent/CO6731081A2/es unknown
-
2015
- 2015-05-05 CL CL2015001180A patent/CL2015001180A1/es unknown
-
2017
- 2017-09-05 HR HRP20171330TT patent/HRP20171330T1/hr unknown
- 2017-09-14 CY CY20171100974T patent/CY1119413T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2015001180A1 (es) | Combinacion farmaceutica que comprende un copolimero de carboximetilcelulosa sodica con un grado de sustitucion de 0,35 a 0,80 y gosipol o un medicamento para el tratamiento de trastornos cognitivos seleccionado de neurolepticos, antidepresivos, anticonvulsivos o una combinacion de los mismos. | |
IT1400982B1 (it) | Collirio osmotico trans-epiteliale per la cura del cheratocono. | |
CL2016002132A1 (es) | Uso de una cantidad de laquinimod, que sirve para preparar un medicamento para tratar un paciente humano afectado con esclerosis múltiple o que presenta un síndrome clínicamente aislado; un paquete, una cantidad de laquinimod y una composición farmacéutica del mismo. | |
DK2148670T3 (da) | Titrering af tapentadol | |
CL2008000691A1 (es) | Compuestos derivados de dihidro y tetrahidro oxazolopirimidinonas sustituidas; composicion farmaceutica que comprende a dichos compuestos; y su uso para el tratamiento de la esquizofrenia, epilepsia, entre otras enfermedades. | |
MX2019003249A (es) | Diagnostico, prevencion y tratamiento de enfermedades de la articulacion. | |
BRPI0816128A2 (pt) | Uso de uma composição de estabilização, composição de estabilização, produto de cuidado corporal, e, produto doméstico. | |
CL2013001436A1 (es) | Composicion que comprende al menos una n-acetil-lactosamina, al menos un oligosacarido sialilado y al menos un oligosacarido fucosilado; y su uso para la prevencion y/o tratamiento de las condiciones de la piel y enfermedades de la piel. | |
BR112012002124A2 (pt) | tratamento da doença de crohn com laquinimode. | |
CL2012002944A1 (es) | Compuestos derivados de amino-pirimidinas; composiciones farmacéuticas que los comprenden; y su uso para el tratamiento de una enfermedad afección seleccionada de trastornos neuromusculares, esclerosis lateral amiotrófica, miastenia grave, entre otras. | |
CL2012002945A1 (es) | Compuestos derivados de amino-piridazinas; composiciones farmacéuticas que los comprenden; y su uso para el tratamiento de una enfermedad afección seleccionada de trastornos neuromusculares, esclerosis lateral amiotrófica, miastenia grave, entre otras. | |
IL211400A0 (en) | Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof | |
BR112012016853A2 (pt) | "composições farmacêuticas para administração oral de peptídeos de insulina". | |
CL2013002241A1 (es) | Compuestos derivados de (4,4´-bifeniilbis(1h-imidazol-4,2-diil)-2,1-pirrolidindiil((1s)-1-((2r,6r)-2,4-dimetilltetrahidro-2h-piran-4-il)-2-oxo-2,1-etandiil)))biscarbamato de dimetilo, inhibidores del vhc; compuestos intermediarios; composicion farmaceutica; combinacion farmaceutica; y uso para tratar una infeccion por vhc. | |
HN2012000023A (es) | Compuestos y composiciones para el tratamiento de enfermedades parasitarias | |
BRPI0815577A2 (pt) | Peptídeo foxm1 e agente medicinal compreendendo o mesmo. | |
SMT201500189T1 (it) | Ligandi sigma per la prevenzione o il trattamento del dolore indotto da chmioterapia | |
BRPI1006040A2 (pt) | uso de composições farmacêuticas, tipo de curativo médico, e, tipo de caixa de medicamento | |
CL2015001374A1 (es) | Compuestos derivados de 2-(metilamino)-n-(2-oxo-2,3,4,5-tetrahidro-1h-1,5-benzodiazepin-3il)propanamida; composicion farmaceutica; y su uso en el tratamiento terapeutico o profilactico del cancer. | |
SI2739615T1 (sl) | Fenil-3-aza-biciklo(3.1.0)heks-3-il-metanoni in njihova uporaba kot zdravilo | |
BRPI1009392A2 (pt) | "formulação farmacêutica, e, uso de uma quantidade farmaceuticamente eficaz de uma formulação farmacêutica." | |
CL2014003429A1 (es) | Compuestos especificos derivados de indanosulfamida; composicion farmaceutica que los comprende, utiles en el tratamiento e la epilepsia. | |
ES2446643R1 (es) | Composiciones farmacéuticas combinadas y su uso para preparar un medicamento destinado al tratamiento del vértigo, la cinetosis y la distonía vegetativa-vascular | |
CL2012003322A1 (es) | Compuestos derivados de benzamida sustituidas; composicion farmacéutica; y uso en el tratamiento del cancer. | |
EA201200485A1 (ru) | Перорально распадающаяся фармацевтическая лекарственная форма, содержащая арипипразол |